'Treatment For Tyrosine Degradation-Associated Disorders' in Patent Application Approval Process (USPTO 20240344072)

Source :: Cancer Gene Therapy Week. November 4, 2024, 483
Publication Year :: 2024
Abstract: 2024 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- A patent application by the inventors Doreste, Bruno (London, GB); Gissen, Paul (London, [...]

Subjects :: Genetic aspects
Intellectual property
Cancer treatment
Cancer genetics -- Genetic aspects
Patient compliance
Tyrosine -- Intellectual property -- Genetic aspects
Nitisinone -- Intellectual property
Phenols (Class of compounds) -- Intellectual property
Phenols -- Intellectual property
Cancer -- Care and treatment -- Genetic aspects

Tools